Sector Cardiol Therapeutics Inc.

Aandelen

CRDL

CA14161Y2006

Biotechnologie & Medisch Onderzoek

Beurs gesloten - 22:00:00 02-09-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
3,010 CAD -0,66% Intraday-grafiek van Cardiol Therapeutics Inc. +1,35% +129,77%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-0,66%+1,35%+56,77%+84,66%+129,77%+98,03%+115,00%-33,26% - 255 mln.
+0,97%-1,75%+3,77%+17,57%+8,48%+2,17%+18,46%-24,64%+215,86% 49,74 mld.
-0,30%-2,88%+14,68%+38,28%+162,69%+429,29%+521,04%+601,64% - 44,98 mld.
+2,13%+0,89%+13,06%+46,06%+17,05%+43,59%+19,44%-0,52%+242,83% 42,52 mld.
+0,87%-3,73%+15,30%+31,70%+19,08%+8,96%+76,62%+8,64%+1.126,79% 40,78 mld.
-0,90%-1,74%-0,21%+2,04%+8,07%+15,20%+48,44%-22,00%+142,12% 32,89 mld.
+2,71%+6,82%+9,80%+23,41% - - - - - 17,09 mld.
+1,68%-4,20%+3,44%+33,09%+5,59%+25,28%+123,70%+205,82%+1.831,66% 16,28 mld.
+1,70%-1,75%+6,78%+17,65%+16,63%+12,00%+28,50%-40,05%+102,17% 14,4 mld.
+3,34%-1,13%+26,37%+66,92%+46,26%+80,94%+42,82%-35,03%+245,61% 13,48 mld.
-0,97%-5,38%+0,90%+16,21%-12,28%-10,12%-38,20%-38,82%+107,21% 12,45 mld.
-0,53%-9,55%+34,51%+24,83%+4,89%-20,93% - - - 11,24 mld.
+0,17%-0,11%+0,22%+45,27%+22,94%+35,34%-6,42%-43,38%+170,58% 11,32 mld.
-1,29%-9,41%+14,27%+71,35%+47,91%+34,17%+42,83%-50,85% - 10,64 mld.
-1,83%-5,52%-9,08%-13,55%-19,73%+43,40%+463,23%+214,82%+2.346,84% 10,68 mld.
-0,01%+0,09%+0,72%+71,60%+78,95%+256,76%+467,52% - - 10,19 mld.
+2,42%-3,20%+12,55%-15,95%-22,48%+6,68%+55,90%+51,25%+108,18% 9,95 mld.
-0,35%-5,51%+18,26%+66,40%+52,46%+191,55%+496,13%+95,47% - 9,9 mld.
+1,15%-5,27%+17,02%+38,52%+21,29%+695,51%+1.543,68%+13,49% - 9,87 mld.
-0,28%-3,58%+10,43%+56,69%+67,25%+148,22%+646,45%+194,40%+1.109,27% 9,48 mld.
Gemiddelde +0,43%-2,75%+12,48%+36,14%+34,47%+110,32%+259,17%+64,53%+645,76% 18,91 mld.
Gewogen gemiddelde per kap. +0,64%-2,82%+9,91%+31,17%+35,74%+104,01%+198,33%+94,07%+553,86%
  1. Beurs
  2. Aandelen
  3. Koers CRDL
  4. Sector Cardiol Therapeutics Inc.